Education
About Us
Working with TipRanks
Follow Us
eXoZymes (EXOZ)
NASDAQ:EXOZ
EXOZ Stock Chart & Stats
Day’s Range― - ―
52-Week Range$8.50 - $23.99
Previous CloseN/A
VolumeN/A
Average Volume (3M)4.06K
Market Cap
N/A
Enterprise Value$77.18M
Total Cash (Recent Filing)$6.99M
Total Debt (Recent Filing)$1.11M
Price to Earnings (P/E)―
Beta1.27
Next Earnings
Apr 08, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.28
Shares Outstanding8,387,250
10 Day Avg. Volume1,653
30 Day Avg. Volume4,057
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/Revenue560.24
Enterprise Value/Gross Profit-540.60
Enterprise Value/Ebitda-8.09
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
eXoZymes News
EXOZ FAQ
What was eXoZymes’s price range in the past 12 months?
eXoZymes lowest stock price was $8.50 and its highest was $23.99 in the past 12 months.
What is eXoZymes’s market cap?
Currently, no data Available
When is eXoZymes’s upcoming earnings report date?
eXoZymes’s upcoming earnings report date is Apr 08, 2026 which is in 222 days.
How were eXoZymes’s earnings last quarter?
eXoZymes released its earnings results on Aug 12, 2025. The company reported -$0.282 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.282.
Is eXoZymes overvalued?
According to Wall Street analysts eXoZymes’s price is currently Overvalued.
Does eXoZymes pay dividends?
eXoZymes does not currently pay dividends.
What is eXoZymes’s EPS estimate?
eXoZymes’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does eXoZymes have?
eXoZymes has 8,387,250 shares outstanding.
What happened to eXoZymes’s price movement after its last earnings report?
eXoZymes reported an EPS of -$0.282 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.399%.
Which hedge fund is a major shareholder of eXoZymes?
Currently, no hedge funds are holding shares in EXOZ
Company Description
eXoZymes
eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.
EXOZ Earnings Call
Q2 2025
0:00 / 0:00
Technical Analysis
Biodexa Pharmaceuticals
―
Salarius Pharmaceuticals
―
Processa Pharmaceuticals
―
GRI Bio
―
Protagenic Therapeutics
―
Ownership Overview
63.33% Insiders
0.80% Mutual Funds
― Other Institutional Investors
35.62% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---